Department of Haematology, Christian Medical College, Vellore, Tamilnadu, India.
Genes Nutr. 2015 Jul;10(4):474. doi: 10.1007/s12263-015-0474-2. Epub 2015 May 30.
The incidence of iron deficiency anemia in pregnancy is high in India where iron supplementation is a regular practice. The response to oral iron is influenced by several factors such as age, body mass index, gravida, socioeconomic status, food, vitamin deficiency and compliance to supplements. The major challenge is to understand the various modulators of iron status in this high-risk group so that we can improve the diagnosis and the management of these patients. The current study was designed to evaluate the iron status during pregnancy and to identify factors which might be influencing their response to oral iron. We investigated a total of 181 pregnant women with anemia (Hb < 11 g/dl) and evaluated the impact of probable factors on anemia and their iron status. Assessment of the response was based on hemoglobin and serum ferritin or transferrin saturation level after 8 and 20 weeks of iron supplementation. Socioeconomic, clinical, hematological, biochemical and genetic factors were all evaluated. Molecular analysis revealed that HFE variant allele (G) (rs1799945) was significantly associated with an adequate response to iron supplementation. We identified five subjects with a sustained poor response, and targeted re-sequencing of eleven iron-related genes was performed in them. We have identified seven novel variants in them, and in silico analysis suggested that these variants may have an iron regulatory effect. Taken together, our findings underscore the association of genetic variants with response to supplements in pregnancy, and they can be extended to other diseases where anemia and iron deficiency coexist.
在印度,缺铁性贫血的发病率很高,而补充铁剂是一种常规做法。口服铁剂的反应受到多种因素的影响,如年龄、体重指数、孕次、社会经济地位、饮食、维生素缺乏和补充剂的依从性。主要的挑战是了解这个高风险人群中各种铁状态的调节剂,以便我们能够改善这些患者的诊断和管理。本研究旨在评估妊娠期间的铁状态,并确定可能影响其对口服铁剂反应的因素。我们共调查了 181 名贫血孕妇(Hb<11g/dl),并评估了可能影响贫血及其铁状态的各种因素。根据血红蛋白和血清铁蛋白或转铁蛋白饱和度在补充铁 8 周和 20 周后的水平来评估反应。评估了社会经济、临床、血液学、生化和遗传因素。分子分析显示 HFE 变异等位基因(G)(rs1799945)与铁补充剂的充分反应显著相关。我们发现了 5 名持续铁反应不良的患者,并对他们的 11 个铁相关基因进行了靶向重测序。我们在他们身上发现了 7 个新的变异体,计算机分析表明这些变异体可能具有铁调节作用。总之,我们的研究结果强调了遗传变异与妊娠期间补充剂反应的相关性,这些结果可以扩展到其他贫血和缺铁并存的疾病。